Sunday, February 5

Tag: FortySix Venture Capital LLC

Technology developed at The University of Tulsa and licensed by FortySix Venture Capital could advance cancer testing and targeted therapeutics
Science

Technology developed at The University of Tulsa and licensed by FortySix Venture Capital could advance cancer testing and targeted therapeutics

TULSA, Okla., Jan. 10, 2023 /PRNewswire/ -- FortySix Venture Capital LLC (46VC) and The University of Tulsa (TU) announced today that technology developed by TU researchers has been licensed by 46VC for commercialization efforts. Researchers at The University of Tulsa have developed a novel process for synthesizing and using sulfonamides and testing their efficacy and selectivity against human cancer cells, which could ultimately aid targeting therapeutic treatments for individualized patient applications. Angus Lamar, Ph.D., and Robert Sheaff, Ph.D., who are both associate professors of chemistry and biochemistry, have been researching cancer at TU for several years funded by a grant from the Oklahoma Center for Advancement of Science and Technology (OCAST). Together with their teams – w...